Categories
Procedure
Prostatic artery embolization (PAE) is a promising non-surgical treatment for lower urinary tract symptoms (LUTS) from benign prostatic hyperplasia (BPH). Clinically shown to reduce BPH symptoms and improve quality of life, PAE has become a viable alternative to surgical procedures, with minimal risk of urinary incontinence or sexual dysfunction such as impotence and retrograde ejaculation. PAE also offers a shorter recovery time compared to surgical options and is performed via the femoral or radial artery.
Using femoral or radial artery access, interventional radiologists navigate microcatheters to the prostatic arteries to deliver embolic agents that reduce blood flow and shrink the enlarged prostate. Merit Medical supports this procedure with a full suite of precision-engineered tools—including microcatheters, guidewires, embolic particles, and access kits—designed to streamline workflow, enhance navigation through complex pelvic vasculature, and ensure optimal embolization. Merit’s PAE solutions are tailored for outpatient or same-day settings that empower providers to deliver effective symptom relief while minimizing patient recovery time and preserving sexual and urinary function.

From set-up and access to hemostasis and including the first and only embolotherapy product with FDA clearance to treat symptomatic BPH via PAE, Merit offers your tools a la carte, or in several convenient packs.

Prepare and protect your patients efficiently and safely.
| PRODUCT | RADIAL | FEMORAL |
|
Embosphere® Procedure Pack – combines the basic products for any embolization procedure into one convenient pack. |
✔ | ✔ |
| ✔ | ✔ | |
| ✔ | ||
| ✔ |
Achieve quick and effective access.
| PRODUCT | RADIAL | FEMORAL |
| ✔ | ||
| ✔ | ||
| ✔ |
Reach challenging anatomy with accuracy.
| PRODUCT | RADIAL | FEMORAL |
| ✔ | ✔ | |
| ✔ | ✔ | |
| ✔ | ||
| ✔ | ✔ | |
| ✔ | ||
| ✔ | ||
| ✔ | ✔ | |
| ✔ | ||
| ✔ | ✔ |
Treat your patients with predictable outcomes.
Read the press release announcing Merit Medical’s Embosphere® Microspheres Receive FDA 513(f)(2) (de novo) Classification for Prostatic Artery Embolization Indication.

Achieve controlled hemostasis accurately, quickly, and comfortably.
| PRODUCT | RADIAL | FEMORAL |
| ✔ | ||
| ✔ | ||
| ✔ |
Ask4PAE aims to educate patients and their families about PAE as a treatment option for BPH. The program includes Ask4PAE.com, as well as patient brochures and other awareness tactics.

For more information please refer to Instructions for Use. Consult product labels and inserts for any indications, contraindications, potential complications, warnings, precautions and directions for use.
References